Acupuncture:

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

 

Acupuncture:

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatments, affecting 30–68% of patients receiving drugs like taxanes or platinum agents. It causes numbness, tingling, and burning pain in the hands and feet, often with weakness or digestive issues, significantly reducing quality of life and sometimes leading to reduced chemotherapy doses or treatment cessation.

While duloxetine (Cymbalta) offers moderate pain relief for many, its side effects that sometimes includes fatigue and nausea limits its use for some patients. Other drugs, such as gabapentin, pregabalin (Lyrica0 often show little benefit for CIPN.  For this reason, many turn to acupuncture as a means of helping them with their pain and other symptoms associated with CIPN.

Summary of Acupuncture for CIPN

Acupuncture has emerged as a safe and effective option to relieve CIPN symptoms, improve nerve function, and enhance quality of life. This summary reviews three systematic research publication reviews of acupuncture’s role in CIPN treatment.

Key Findings

  • Acupuncture Reduces Pain and Symptoms: Across 49 randomized controlled trials (RCTs) involving 3,218 patients, acupuncture significantly reduced pain, severity of CIPN sensory symptoms like numbness and tingling), particularly for mild to moderate cases. It outperforms vitamin B, vitamin B12 and neurotrophic drugs like gabapentin and Lyrica in improving symptoms.
  • Improves Nerve Function: Acupuncture enhances nerve conduction velocity (NCV), with stronger effects on motor nerves than sensory nerves and supports recovery of nerve function damaged by chemotherapy.
  • Enhances Quality of Life: Acupuncture improved CIPN-specific quality of life with additional benefits for chemotherapy-related symptoms like nausea and fatigue, indicating broader systemic effects.
  • Electroacupuncture’s Role: Electroacupuncture (EA) shows superior efficacy in some studies, particularly when combined with glutathione or vitamin B12, but may worsen pain in severe CIPN cases, suggesting traditional acupuncture as a safer option for some patients.
  • Safety: Acupuncture and EA reported minimal adverse events, such as mild bruising, making them safe options for patients seeking alternatives to medications with side effects.

Summary

Patients may expect reduced symptoms and improved daily functioning with low-risk  acupuncture therapy, especially those with sensory symptoms and those unable to tolerate duloxetine. .

Limitations

Research evidence is limited by small sample sizes, lack of blinding in many studies, and variability in treatment protocols and outcome measures, which complicates comparisons. No studies compared acupuncture directly to duloxetine, and long-term effects remain unstudied, necessitating cautious interpretation.

Recommendations

Acupuncture should be considered a first-line complementary therapy for CIPN, particularly for mild to moderate sensory symptoms.

References

  • Li et al. (2024). Frontiers in Neurology. DOI: 10.3389/fneur.2024.1351228
  • Jin et al. (2020). DOI not provided.
  • Pei et al. (2023). Acupuncture in Medicine. DOI: 10.1177/09645284221076512

 

References

Acupuncture – Diabetic Peripheral Neuropathy (DPN)

  1. Acupuncture in Patients with Diabetic Peripheral Neuropathy-Related Complaints- A Randomized Controlled Clinical Trial – 2023
  2. Research trends of acupuncture therapy for painful peripheral nervous system diseases from 2004 to 2023- a bibliometric and meta-analysis – 2025

 

Acupuncture – Chemotherapy-Induced Peripheral Neuropathy (CIPN)

  1. Research trends of acupuncture therapy for painful peripheral nervous system diseases from 2004 to 2023- a bibliometric and meta-analysis – 2025
  2. Acupuncture in the treatment of chemotherapy-induced peripheral neuropathy- a meta-analysis and data mining – 2024
  3. Chemotherapy-Induced Peripheral Neuropathy- A Recent Update on Pathophysiology and Treatment – 2024
  4. Corrigendum- Exercise for reducing chemotherapy-induced peripheral neuropathy- a systematic review and meta-analysis of randomized controlled trials – 2024
  5. The effectiveness and safety of acupuncture_electroacupuncture for chemotherapy-induced peripheral neuropathy_ a systematic review and meta-analysis – PubMed – 2023
  6. Acupuncture for chronic pain- update of an individual patient data meta-analysis – 2018

 

 

Acupuncture – Other

  1. Pain management with acupuncture in osteoarthritis – A systematic review and meta-analysis
  2. Mechanism of Traditional Chinese Medicine in Treating Migraine- A Comprehensive Review

 

 

 

 

 

 

 

 

Emphasis on Education

 

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

 

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

 

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

 

For more information, please contact Accurate Clinic.

 

 

.